MedPath

Comparison of ACTIVA BioACTIVE Versus Compomer in Restoring Dental Decay in Primary Molar Teeth

Phase 4
Completed
Conditions
Dental Caries in Children
Interventions
Drug: Compomer
Drug: ACTIVA™ BioACTIVE
Registration Number
NCT03516838
Lead Sponsor
University Ghent
Brief Summary

A clinical trial to evaluate a filling material (ACTIVA) and compare it to a traditional filling material (compomer) to restore decayed deciduous teeth in children

Detailed Description

A tooth decay in deciduous teeth has to be restored with proper filling material. ACTIVA™ BioACTIVE is a new filling material which has the ability to release and recharge fluoride in the oral cavity which is important for preventing further tooth decay. In this study we will compare this new filling material with Compomer (the traditional control filling material) by restoring decayed deciduous molars with one of the mentioned filling materials.

Both filling materials have no reported adverse effect and used regularly in the dental practice.

The treatment procedure is performed in healthy children from both genders with decayed deciduous molars aged between 5 to 10 years by one operator in the dental chair under local anesthesia in the department of pediatric dentistry and special care, Ghent University hospital, Ghent, Belgium.

At least 35 teeth is needed to demonstrate an effect. Each material is placed randomly based on randomization done by the computer. Each participant will receive both types of treatments, one type on each side of the mouth.

The participants will come back each six months to check the success of each treatment group by two trained dentists other than the operator. and to check whether the control group performs similar, better or worse than the control group.

The duration of treatment procedure of both treatment groups is recorded and compared to check if one filling material takes less time than the other to placed in the oral cavity.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Healthy children with American Society of Anesthesiologists (ASA) I score from both gender aged between three and ten years
  • Vital decayed deciduous molar with proximal enamel/dentine caries
  • At least one decayed tooth on each side of the mouth (split mouth)
  • Pt is treatable in the dental chair
  • Parents agreed to participate in the study and signed the informed consent
Exclusion Criteria
  • Patients with medical conditions or systemic disease
  • Anxious or uncooperative patients who are not treatable in the dental chair
  • Any symptoms like: pain, swelling, abscess or fistula.
  • Extensive caries, dental developmental disturbance, pathological mobility, pulp exposure or indication for pulp therapy
  • Patients with one decayed tooth in the whole mouth (not split mouth)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
CompomerCompomerRestoring cavity using compomer filling material
ACTIVA™ BioACTIVEACTIVA™ BioACTIVERestoring cavity using ACTIVA filling material
Primary Outcome Measures
NameTimeMethod
Clinical evaluation12 months follow-up

Check the filling clinically based on United States Public Health Ryge criteria by a blinded and calibrated assessor

Radiographic evaluation12 months follow-up

Check the filling radiographically based on Rx photo by a blinded and calibrated assessor

Secondary Outcome Measures
NameTimeMethod
Time needed to place the filling materialImmediately after each intervention

Time since start placing the filling material until finishing the restoration is recorded and compared between the two groups to investigate whether both materials take the same time to be placed in the oral cavity.

Trial Locations

Locations (1)

Ghent University hospital

🇧🇪

Ghent, Flanders, Belgium

© Copyright 2025. All Rights Reserved by MedPath